Title of Invention

A PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A CANCER

Abstract An isolated polypeptide comprising at least an immunogenic portion of an ovarian carcinoma protein, or a variant thereof that differs in one or more substitutions, deletions, additions and/or insertions such that the ability of the variant to react with antigen specific antisera is not substantially diminished, wherein the ovarian carcinoma protein comprises an amino acid sequence that is encoded by a polynucleotide sequence selected from the group consisting of: a) polynucleotides recited in any one of SEQ ID NOs:1-81, 313-331, 359,366,379,385-387 or 391 and b) complements of the foregoing polynucleotides.
Full Text

Documents:

IN-PCT-2001,00727-MUM-COPY OF US ASSIGNMENT(17-9-2008).pdf

IN-PCT-2001,00727-MUM-CORRESPONDENCE(17-9-2008).pdf

IN-PCT-2001,00727-MUM-DESCRIPTION(COMPLETE)-(17-9-2008).pdf

in-pct-2001,00727-mum-form 13(17-9-2008).pdf

IN-PCT-2001,00727-MUM-FORM 1A(17-9-2008).pdf

in-pct-2001,00727-mum-form 2(17-9-2008).pdf

IN-PCT-2001,00727-MUM-FORM 2(TITLE PAGE)-(17-9-2008).pdf

IN-PCT-2001,00727-MUM-FORM 5(17-9-2008).pdf

IN-PCT-2001,00727-MUM-PETITION UNDER RULE 138(17-9-2008).pdf

IN-PCT-2001,00727-MUM-POWER OF AUTHORITY(17-9-2008).pdf

IN-PCT-2001-00727-MUM-ABSTRACT(17-9-2008).pdf

IN-PCT-2001-00727-MUM-ABSTRACT(24-2-2009).pdf

IN-PCT-2001-00727-MUM-ABSTRACT(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-ASSIGNMENT(17-9-2008).pdf

IN-PCT-2001-00727-MUM-CANCELLED PAGES(24-2-2009).pdf

IN-PCT-2001-00727-MUM-CLAIMS(18-6-2001).pdf

IN-PCT-2001-00727-MUM-CLAIMS(24-2-2009).pdf

IN-PCT-2001-00727-MUM-CLAIMS(AMENDED)-(17-9-2008).pdf

IN-PCT-2001-00727-MUM-CLAIMS(AMENDED)-(24-2-2009).pdf

IN-PCT-2001-00727-MUM-CLAIMS(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-CORRESPONDENCE(24-2-2009).pdf

IN-PCT-2001-00727-MUM-CORRESPONDENCE(4-11-2010).pdf

IN-PCT-2001-00727-MUM-CORRESPONDENCE(9-3-2009).pdf

IN-PCT-2001-00727-MUM-CORRESPONDENCE(IPO)-(24-5-2011).pdf

IN-PCT-2001-00727-MUM-DESCRIPTION(COMPLETE)-(18-6-2001).pdf

IN-PCT-2001-00727-MUM-DESCRIPTION(COMPLETE)-(24-2-2009).pdf

IN-PCT-2001-00727-MUM-DESCRIPTION(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-FORM 1(17-9-2008).pdf

IN-PCT-2001-00727-MUM-FORM 1(18-6-2001).pdf

IN-PCT-2001-00727-MUM-FORM 18(3-1-2006).pdf

in-pct-2001-00727-mum-form 2(24-2-2009).pdf

IN-PCT-2001-00727-MUM-FORM 2(COMPLETE)-(18-6-2001).pdf

IN-PCT-2001-00727-MUM-FORM 2(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-FORM 2(TITLE PAGE)-(24-2-2009).pdf

IN-PCT-2001-00727-MUM-FORM 2(TITLE PAGE)-(COMPLETE)-(18-6-2001).pdf

IN-PCT-2001-00727-MUM-FORM 2(TITLE PAGE)-(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-FORM 3(18-6-2001).pdf

IN-PCT-2001-00727-MUM-FORM 3(2-9-2008).pdf

IN-PCT-2001-00727-MUM-FORM 5(18-6-2001).pdf

IN-PCT-2001-00727-MUM-PETITION UNDER RULE 138(17-9-2008).pdf

IN-PCT-2001-00727-MUM-POWER OF AUTHORITY(17-9-2008).pdf

IN-PCT-2001-00727-MUM-POWER OF AUTHORITY(8-1-2002).pdf

IN-PCT-2001-00727-MUM-SEQUENCE LISTING(18-6-2001).pdf

IN-PCT-2001-00727-MUM-SEQUENCE LISTING(GRANTED)-(21-4-2011).pdf

IN-PCT-2001-00727-MUM-SEQUENCE_LISTING.pdf

IN-PCT-2001-00727-MUM-SPECIFICATION(AMENDED)-(17-9-2008).pdf

IN-PCT-2001-00727-MUM-WO INTERNATIONAL PUBLICATION REPORT(18-6-2001).pdf


Patent Number 247571
Indian Patent Application Number IN/PCT/2001/00727/MUM
PG Journal Number 17/2011
Publication Date 29-Apr-2011
Grant Date 21-Apr-2011
Date of Filing 18-Jun-2001
Name of Patentee CORIXA CORPORATION
Applicant Address SUITE 200, 1124 COLUMBIA STREET, SEATTLE, WA 98104.
Inventors:
# Inventor's Name Inventor's Address
1 GORDON E. KING 1530 NW 52nd #304, SEATTLE, WA 98107.
2 PAUL A. ALGATE 2010 FRANKLIN AVENUE E., #301, SEATTLE, WA 98102.
3 TONY N. FRUDAKIS 7937 BROADMOOR PINES BOULEVARD, SARASOTO, FL 34243.
4 JENNIFER L. MITCHAM 16677 NORTHEAST 88th STREET, REDMOND, WA 98052.
PCT International Classification Number C12N15/12 C07K14/47
PCT International Application Number PCT/US99/30270
PCT International Filing date 1999-12-17
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 09/338,933 1999-06-23 U.S.A.
2 09/404,879 1999-09-24 U.S.A.
3 09/215,681 1998-12-17 U.S.A.
4 09/216,003 1998-12-17 U.S.A.